# Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)

> **NCT07322133** · PHASE4 · RECRUITING · sponsor: **University of California, Davis** · enrollment: 30 (estimated)

## Conditions studied

- Hypotension and Shock
- Pulmonary Hypertension of the Newborn (PPHN)
- Hypoxemic Respiratory Failure

## Interventions

- **DRUG:** Dopamine administration
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT07322133
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07322133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07322133, "Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07322133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*